StockWatch
·

Vivanza Biosciences Ltd Q1 FY27 Results

VIVANZAQ1 FY27 Results
Filing
Result:Weak· Market: Flat#Base effect#Margin squeeze
MetricValue (₹ Cr)Q4 FY26Q1 FY26
Revenue9.2946.0%3.9%
Total Income9.6651.6%7.9%
Expenditure9.4842.1%6.9%
PBT0.18160.5%109.8%
Net Profit0.15132.5%68.7%
OPM-0.85%2.81pp2.52pp
NPM1.52%8.60pp0.55pp
EPS0.0463.6%100.0%
View full financials

Revenue growth stalled at 3.9% and operating margin turned negative (-0.85% vs 1.67% YoY) even as the 68.7% PAT jump is just a base-effect swing on a trivial ~₹0.15cr absolute profit.

Informational and educational content only. Not investment advice.